Patients needing reconstruction after head and neck cancer ablation, including oral, pharyngeal, facial, and craniofacial defects, especially high-risk cases after chemoradiation or repeated surgery.

The Kaohsiung Chang Gung Head and Neck Cancer Reconstruction Team provides microvascular free flap reconstruction for patients after head and neck tumor ablation. The team integrates multidisciplinary care from plastic surgery, otolaryngology, anesthesia, nursing, nutrition, rehabilitation, and case management. We have established standardized clinical pathways, digital flap monitoring, abnormality reporting systems, patient education tools, nutritional intervention, pain control, and early mobilization strategies. Through this integrated model, postoperative care is transformed from passive recovery to proactive enhanced recovery. The team also continues to develop innovative reconstructive techniques, translational research, international academic collaboration, and professional training. Our goal is to help patients restore appearance, swallowing, speech, airway function, and overall quality of life after head and neck cancer treatment.

• Precision microvascular free flap reconstruction to restore appearance, swallowing, speech, and airway function

• Multidisciplinary integrated care with standardized ERAS pathways for postoperative head and neck cancer reconstruction

• Digital flap monitoring and reporting systems to enhance real-time assessment and timely intervention

• Integrated nutritional support, pain control, early mobilization, and diverse patient education tools

• Continuous development of innovative reconstructive techniques, translational research, and international knowledge sharing

• The reconstructive plastic surgery team consists of 18 members, including 9 attending physicians, 6 residents, and 3 nurse practitioners

• The team serves more than 200 head and neck cancer reconstruction patients annually, providing preoperative evaluation, microvascular reconstruction, and integrated postoperative care

• More than 2,000 head and neck cancer microvascular free flap reconstructions have been completed over the past decade

• A standardized ERAS care pathway has been established for postoperative head and neck cancer reconstruction, covering flap monitoring, nutritional intervention, pain control, and early mobilization

• Clinical outcomes are continuously monitored, including surgical success rate, length of hospital stay, complications, and quality of life indicators

• More than 200 head and neck cancer reconstruction patients served annually

• Free flap survival rate reached 97.95%

• Flap-related surgical complication rate decreased by 76%

• Post-reconstruction hospital stay shortened by 3.4 days

• Patient care satisfaction improved to over 90%

• Cancer Center accredited at the highest level

• Microvascular reconstruction outcomes recognized internationally

• Continuous SCI publications in head and neck reconstruction

• Extensive experience in international invited lectures and medical conferences

• Long-term support and recognition from national research grants

• ERAS pathway key elements achieved a 95% compliance rate

• Flap perfusion assessment time was reduced by 72.2%

• Perfusion assessment time decreased to 2.5 minutes

• Zero abnormalities related to the flap reporting process

• Digital handoff accuracy reached 100%

• Patient care satisfaction consistently maintained above 90%

• Postoperative anxiety score decreased to 3 points

• Diverse patient education improved understanding of care

• Family feedback indicated greater reassurance after preoperative education

• Nursing and nutritional guidance reduced post-discharge anxiety

• Patient self-care ability was significantly improved

• 22 SCI-indexed international publications

• Co-editor of 1 international textbook

• Author of 6 international textbook chapters

• Featured as an international ZEISS KOL

• Visiting scholar exchanges in Europe, including Germany, Austria, Switzerland, the Czech Republic, and Italy

• Visiting professorships at leading U.S. medical centers, including NYU Langone Health, Mayo Clinic, Northwestern Memorial Hospital, and UCHealth PRS Anschutz Medical Campus

• Invited co-chair of the head and neck cancer reconstruction collaborative training program at University of Santo Tomas Hospital, Philippines

• Established standardized pathways for head and neck microvascular reconstruction and ERAS, improving care quality and patient safety

• Trained 9 international physicians from 6 countries between 2019 and 2025, including the Philippines, Peru, Romania, Czech Republic, Italy, and India, promoting global knowledge transfer in microsurgical reconstruction

• Continued to advance innovative reconstruction, international collaboration, and translational research, expanding global medical impact